Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A term that refers to germinoma, seminoma, or dysgerminoma.
Biomarker and diagnostic research for germinomatous germ cell tumor has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
5 publications have been identified in PubMed for germinomatous germ cell tumor. Research spans Review / Meta-Analysis (40%), Diagnostic / Biomarker (20%), and Clinical Trial Publication (20%).
Faure Conter C (2026). [PMID: 42115464](https://pubmed.ncbi.nlm.nih.gov/42115464/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Zhang A (2026). [PMID: 41675560](https://pubmed.ncbi.nlm.nih.gov/41675560/). *Neurooncol Adv*. [Clinical Trial Publication]
Deng G (2025). [PMID: 40117133](https://pubmed.ncbi.nlm.nih.gov/40117133/). *Int J Radiat Biol*. [Epidemiology / Natural History]
Takami H (2025). [PMID: 41198340](https://pubmed.ncbi.nlm.nih.gov/41198340/). *Adv Cancer Res*. [Review / Meta-Analysis]
Zhang YT (2024). [PMID: 39189644](https://pubmed.ncbi.nlm.nih.gov/39189644/). *Pediatr Blood Cancer*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC